Logo

mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say

mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say

The vaccine reportedly thwarted the cancer's return and spread.

👉 Full Story